Live from the NIH registry
Studies recruiting near Syracuse right now
Top 25 of 244 recruiting studies, sorted by proximity — each links to its official registry page
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE), Lupus Nephritis
N/A
Observational 3,500 participants sought
SUNY Upstate — Syracuse, New York (0.5 mi)
· Sponsor: Lupus Research Alliance
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: NRG Oncology
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50241 — Syracuse, New York (0.5 mi)
· Sponsor: UCB Biopharma SRL
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Syracuse, New York (0.5 mi)
· Sponsor: Sameek Roychowdhury
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: Children's Oncology Group
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Aortic Valve Stenosis, Aortic Valve Regurgitation
N/A
Interventional 310 participants sought
St-Joseph's Health INC — Syracuse, New York (0.5 mi)
· Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
AI-Assisted Treatment for Residual Speech Sound Disorders
Speech Sound Disorder
N/A
Interventional 26 participants sought
Syracuse University — Syracuse, New York (0.5 mi)
· Sponsor: Syracuse University
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
SUNY Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: Hoffmann-La Roche
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
Aortoiliac Occlusive Disease
N/A
Observational 158 participants sought
Research Foundation at SUNY Syracuse — Syracuse, New York (0.5 mi)
· Sponsor: W.L.Gore & Associates
Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief
Neck Pain Musculoskeletal, Neck Pain Treatment
N/A
Interventional 160 participants sought
PROActivePT — Syracuse, New York (0.5 mi)
· Sponsor: Baylor University
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
Venous Thromboembolism, Head and Neck Cancer
Phase 4
Interventional 76 participants sought
SUNY Upstate — Syracuse, New York (0.5 mi)
· Sponsor: Kiranya Arnold
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Phase 3
Interventional 750 participants sought
Hematology Oncology Association of Central New York — East Syracuse, New York (3.7 mi)
· Sponsor: Amgen
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
Mood Disorders, Anxiety Disorders
N/A
Interventional 2,500 participants sought
SUNY Upstate Medical University, Department of Psychiatry and Behavioural Sciences — Syracuse, New York (0.5 mi)
· Sponsor: Parnassia Groep
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Epilepsy, Temporal Lobe
Phase 1, Phase 2
Interventional 10 participants sought
SUNY Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: Neurona Therapeutics
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone-sensitive Prostate Cancer
Phase 2
Interventional 150 participants sought
Associated Med Professionals of NY — Syracuse, New York (0.5 mi)
· Sponsor: Novartis Pharmaceuticals
Quality of End-of-Life Care for Children With Cancer
Childhood Hematopoietic and Lymphatic System Neoplasm, Childhood Malignant Solid Neoplasm
N/A
Observational 2,425 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: Children's Oncology Group
Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy
Pediatric Patients Treated With Radiation Therapy
N/A
Observational 5,000 participants sought
State University of New York Upstate Medical Center — Syracuse, New York (0.5 mi)
· Sponsor: Massachusetts General Hospital
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Non-Small Cell Lung Cancer
Phase 3
Interventional 272 participants sought
SUNY - Upsate Medical Centre — Syracuse, New York (0.5 mi)
· Sponsor: University of Texas Southwestern Medical Center
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Diabetic Nephropathies, Kidney Failure, Chronic
Phase 3
Interventional 150 participants sought
SUNY Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: Alessandro Doria
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
Hematology Oncology Associates of Central New York — Camillus, New York (8.1 mi)
· Sponsor: Jazz Pharmaceuticals